📣 Abstract submission DEADLINE 🚨 TODAY ‼️ August 7, 2026 at 5pm EST 📝 www.aepmossociety.org/meetings ✍️ Registration is now OPEN for the 24th AE-PCOS Society Annual Meeting! ”PMOS Across the Life Course" 📍 Kittilä, Lapland, Finland 🇫🇮 🗓️ December 10-12, 2026 Full details available on our website.

Live International Society of Endocrinology webinar: 🎤 Global Name Change for Polycystic Ovary Syndrome - The Why, How, What and What is Next 🔗 www.isendo.org/event/ise-we... 🗓️ August 19, 2026 @ 1:30 pm (CEST)

📣 Abstract submission deadline is THIS FRIDAY, August 7, 2026 at 5:00pm EST 📝 www.aepmossociety.org/meetings ✏️ Registration is OPEN for the 24th AE-PCOS Annual Meeting! ”PMOS Across the Life Course" 📍 Kittilä, Lapland, Finland 🇫🇮 🗓️ December 10-12, 2026 More info: www.aepmossociety.org/meetings

📣 Deadline EXTENDED for Abstract Submission 👉 August 7, 2026 at 5:00pm EST ”PMOS Across the Life Course" Details about the hotel & conference center, plus preliminary program are available on our website: www.aepmossociety.org/meetings 📍 Kittilä, Lapland 🇫🇮 🗓️ Dec 10-12, 2026

Two timely sessions by the International Society of Endocrinology - ISE 💫 🗓️ 19 Aug 🎤 Global Name Change for Polycystic Ovary Syndrome – The Why, How, What and What is Next 🗓️ 28 Sep 🎤 The Pandemic of Insulin Resistance, Metabolic and Reproductive Disorders 👉 Register now: www.isendo.org/event/

Registration is NOW OPEN! 📣 ”PMOS Across the Life Course" Details about the hotel & conference center, plus preliminary program are available on our website: www.aepmossociety.org/meetings 📍 Kittilä, Lapland 🇫🇮 🗓️ Dec 10-12, 2026 ⏳ Abstract submission deadline: July 31, 2026, 5:00pm EST.

✍️ You are invited to submit abstracts of your original research to be considered for presentation at our 24th Annual Meeting. www.aepmossociety.org/meetings 🗓️ December 10-12, 2026 📍 Kittilä, Lapland, Finland "PMOS Across the Life Course" #PCOSnewname #PolyendocrineMetabolicOvarianSyndrome #PMOS

This large nationwide population-based study showed an increased risk of multiple reproductive cancers in reproductive age women w/ polyendocrine metabolic ovarian syndrome PMOS (formerly polycystic ovary syndrome PCOS) compared to those without PMOS/PCOS. doi.org/10.1016/j.fe...

📣 HOLD THE DATE! 👉 ABSTRACT SUBMISSION opens June 1, 2026 (closes July 31, 2026) 🤩 24th Annual Meeting “PMOS / PCOS Across the Life Course” 📍 Kittilä, Lapland 🇫🇮 🗓️ December 10-12, 2026 More information on our website: ae-society.org/meetings/

Dr Madhuri Patil, president-elect of the Indian Society for Assisted Reproduction and one of the clinicians involved, said the inclusion of “metabolic” in the new name is especially relevant given India’s high rates of metabolic syndrome and insulin resistance. #PMOS #pcosnamechange #pcos

PCOS has a new name: Here’s why experts say it matters for millions of women

A global medical consensus has renamed the condition PMOS, saying the old term misunderstood a complex hormonal disorder affecting one in eight women

indianexpress.com

“With the advances in understanding this condition, the new name is more comprehensive.” says Anuja Dokras, MD, PhD, a professor of women’s health and director of the Penn PCOS Center at the Perelman School of Medicine in Philadelphia. Read the full article: www.everydayhealth.com/pcos/myths-d...

Long Misunderstood, PCOS Gets Renamed as PMOS (Polyendocrine Metabolic Ovarian Syndrome)

Persistent misconceptions have made this hormonal disorder difficult to diagnose. Here we dispel 10 common myths about the condition.

everydayhealth.com

Lorna Berry, a patient with #PMOS who worked on the initiative, said last year that she hoped the change would lead to "better outcomes for women with #PCOS across their lifetime". Read the full article on @sciencealert.com.web.brid.gy: www.sciencealert.com/pcos-is-offi... #pcosnamechange

PCOS Is Officially Renamed, After Decades of Misinformation

First, it was named after two men.

sciencealert.com

📣 #pcosnamechange Polyendocrine Metabolic Ovarian Syndrome #PMOS is the new name for the condition previously known as Polycystic Ovary Syndrome #PCOS, which impacts 1 in 8, or more than 170 million women worldwide. 📄 Resources in multiple languages are available: www.mchri.org.au/guidelines-r...

www.youtube.com/watch?v=aPea... #PCOSnamechange #PMOS Polyendocrine Metabolic Ovarian Syndrome

PCOS Name change

YouTube video by MCHRI

youtube.com

PCOS has a new name - Polyendocrine Metabolic Ovarian Syndrome (PMOS). An accurate name for a condition affecting 170 million women globally. Patients & professionals working together from the start. More information at: bit.ly/3R0pIYw #PCOSNameChange #PMOS #PCOS

Finally, polycystic ovary syndrome #PCOS has a new name: polyendocrine metabolic ovarian syndrome #PMOS 👉 better reflecting the complex hormonal and metabolic nature of this condition affecting 170 million women worldwide. Read more here: www.thelancet.com/journals/lan...

Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process

Polyendocrine metabolic ovarian syndrome (PMOS), previously named polycystic ovary syndrome (PCOS), affects one in eight women. However, the term PCOS is inaccurate, implying pathological ovarian cyst...

thelancet.com

Delighted to have been part of this international consensus on the renaming of #PCOS, a lifelong metabolic disorder affecting 15% of women, to Polyendocrine Metabolic Ovarian Syndrome #PMOS share.google/EkubYi5BLx83...

‘Unprecedented’ global effort gives new name to polycystic ovary syndrome – and new hope to millions of women

Decades-long campaign powered by patient perspectives results in switch from PCOS – a name that caused confusion and undue suffering – to PMOS

share.google

Polyendocrine metabolic ovarian syndrome (PMOS) ‘Unprecedented’ global effort gives new name to polycystic ovary syndrome – and new hope to millions of women www.theguardian.com/society/ng-i... @veritypcos.bsky.social Prof @helenateede.bsky.social

‘Unprecedented’ global effort gives new name to polycystic ovary syndrome – and new hope to millions of women

Decades-long campaign powered by patient perspectives results in switch from PCOS – a name that caused confusion and undue suffering – to PMOS

theguardian.com

📣 The name of PCOS is changing. 🤝 The new name was decided after survey answers from 22,000 individuals including patients, their family members, and health professionals. 56 organizations (societies, patient organizations) were involved. The name will be revealed May 12 at #ECE2026 in Prague 🇨🇿

📄 SESSION 4 Tanja Turunen Melanie Cree 🎤 Lina Schiffer MRC Laboratory of Medical Sciences, London 🇬🇧 "Inhibition of the androgen-activating enzyme AKR1C3 selectively decreases systemic and intra-adipose 11-oxygenated androgens in women"

📄 SESSION 4 Tanja Turunen Melanie Cree 🎤 Manuel Tena-Sempere University of Córdoba 🇪🇸 "Targeting cannabinoids and incretins in the treatment of PCOS"

📄 SESSION 3 Co-Chairs:
Nathalie di Clemente @sandrograca.bsky.social 🎤 Farheen Shaikh Zydus Therapeutics Inc 🇺🇸 “Saroglitazar / PPAR gamma agonist in PCOS treatment”

⚡ RAPID-FIRE TALKS (Session 2) 🎤 Christophe Richer dit Laflèche Université de Sherbrooke 🇨🇦 🎤 Martina Curcio University of Udine 🇮🇹 🎤 Tamara Baltic 🇬🇷 🎤 Saad Amer Nuffield Health Derby Hospital 🇬🇧 🎤 Jacob Short Karolinska Institutet 🇸🇪

SESSION 2, co-chaired by:
Damian Romero Lulia-Alexandra Pirga 🎤 Dorte Glintborg University of Southern Denmark 🇩🇰 "Increased prospective cardiovascular disease risk in 127,517 Nordic women with polycystic ovary syndrome. A national cohort study."

📄 SESSION 2, co-chaired by:
Damian Romero Lulia-Alexandra Pirga 🎤 Irem Sonmezoglu Kutuk Hacettepe University School of Medicine 🇹🇷 "Reduced circulating and skeletal muscle MOTS-c expression in women with polycystic ovary syndrome: Evidence for disrupted mitochondrial-derived peptide regulation”

📄 SESSION 2 Co-Chairs:
Damian Romero Lulia-Alexandra Pirga 🎤 Mojca Jensterle University of Ljubljana 🇸🇮 “GLP-1 and GLP-1/GIP receptor agonists in PCOS treatment”

📋 SESSION 1, co-chaired by: Prof. Dr. Mojca Jensterle Sever
Anja Dekanski 🎤 Damian Romero Mississippi Medical Center 🇺🇸 "Targeting the Androgen Receptor to Treat Cardiometabolic Complications in PCOS"

📄 SESSION 1, co-chaired by: Prof. Dr. Mojca Jensterle Sever
Anja Dekanski 🎤 Prof @helenateede.bsky.social Monash University 🇦🇺 "Limited utility of cluster analysis in polycystic ovary syndrome for defining clinically meaningful subtypes and case–control discrimination in unselected populations"

📋 SESSION 1 Prof. Dr. Mojca Jensterle Sever
Anja Dekanski 🎤 Tanja Turunen @ki.se 🇸🇪 "Cell type-specific endometrial dysfunctions across the menstrual cycle in polycystic ovary syndrome"

SESSION 1 Co-chaired by Prof. Dr. Mojca Jensterle Sever & Anja Dekanski 🎤 Nathalie di Clemente Inserm, Sorbonne Université 🇫🇷 "A blocking antibody against anti-Müllerian hormone restores ovulation and normal androgen levels in a spontaneous rat model of polycystic ovary syndrome"